A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease

Recruiting

Phase 1

BepirovirsenA Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease

Sponsor:

GlaxoSmithKline

Code:

NCT07168356

Conditions

Hepatitis B

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

Bepirovirsen

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-20. This information was provided to ClinicalTrials.gov by GlaxoSmithKline on 2025-10-15.